• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Stroke prevention with a high risk strategy of treating hypertension in patients after a transient ischemic attack].

作者信息

Brainin M, Dachenhausen A, Steiner M M

机构信息

Donau-Universität Krems, Maria Gugging.

出版信息

Wien Med Wochenschr. 1997;147(2):34-6.

PMID:9139469
Abstract

High-risk strategies represent important preventive measures that focus on individuals with a defined high risk of suffering a chronic disease. They are valuable in addition to measures of prevention within the general population. One example for a high-risk approach for stroke prevention is the treatment of hypertension in individuals that have previously suffered a transient ischemic attack (TIA). Data from the Klosterneuburg Stroke Data Bank and other sources enable an estimate of 2000 TIAs occurring in Austria each year, half of them being hypertensives that are mostly not treated or not sufficiently treated for their hypertension. A high-risk programme that implies forced and effective treatment of hypertension would prevent some 400 strokes or 3% of 16,000 first-ever strokes per year. Costs for preventing one stroke by means of Betablocker agents would amount to ATS 3500 and by ACE-inhibitor agents ATS 11,500, respectively. In addition to general preventive measures, such a programme would have an important impact on stroke incidence and public health.

摘要

相似文献

1
[Stroke prevention with a high risk strategy of treating hypertension in patients after a transient ischemic attack].
Wien Med Wochenschr. 1997;147(2):34-6.
2
[Cerebrovascular sequelae of hypertension].[高血压的脑血管后遗症]
Herz. 2003 Dec;28(8):707-16. doi: 10.1007/s00059-003-2512-x.
3
Is the pharmacological treatment of mild to moderate hypertension cost effective in stroke prevention?轻度至中度高血压的药物治疗在预防中风方面是否具有成本效益?
N Z Med J. 1988 Apr 13;101(843):167-71.
4
Evaluation of antihypertensive therapy among ischemic stroke survivors: impact of ischemic heart disease.评价缺血性脑卒中幸存者的降压治疗:缺血性心脏病的影响。
J Cardiovasc Pharmacol Ther. 2010 Sep;15(3):282-8. doi: 10.1177/1074248410368049. Epub 2010 May 14.
5
The cost-effectiveness of hypertension treatment in Sweden: an analysis of the criteria for intervention and the choice of drug treatment.瑞典高血压治疗的成本效益:干预标准与药物治疗选择的分析
J Hum Hypertens. 1996 Feb;10 Suppl 2:S23-6.
6
Transient ischemic attacks: Part II. Treatment.短暂性脑缺血发作:第二部分。治疗。
Am Fam Physician. 2004 Apr 1;69(7):1681-8.
7
Antihypertensive and lipid lowering treatment in stroke prevention: current state and future.预防卒中的降压和降脂治疗:现状与未来
Acta Neurol Belg. 2005 Jun;105(2):57-61.
8
Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.老年单纯收缩期高血压患者的心血管事件。STOP-Hypertension-2研究中治疗策略的亚组分析。
Blood Press. 2004;13(3):137-41. doi: 10.1080/08037050410014944.
9
Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.尼日利亚一家三级医院高血压药物治疗的趋势变化:对新旧抗高血压药物的疗效、安全性、合理性和药物经济学的真实世界评估
J Hum Hypertens. 2003 Apr;17(4):277-85. doi: 10.1038/sj.jhh.1001538.
10
[Reduced risk of stroke recurrence due to hypotensive medication, irrespective of the initial blood pressure].[降压药物可降低中风复发风险,与初始血压无关]
Ned Tijdschr Geneeskd. 2002 Mar 2;146(9):398-9.